Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Dec 23, 2025

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

138 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1762
Chunghwa Chemical Synthesis & Biotech
NT$24.75-1.2%-25.3%NT$1.9bNT$28.00PS1.9xE147.8%0.8%
6919
Caliway Biopharmaceuticals
NT$161.002.2%161.4%NT$249.7bNT$240.00PS7136.2xE124.6%n/a
6446
PharmaEssentia
NT$496.00-2.9%-9.3%NT$183.4bNT$641.66PE38.2xE51.5%0.2%
1789
ScinoPharm Taiwan
NT$17.452.0%-20.9%NT$13.8bNT$18.00PE71.5xE37.8%2.0%
1795
Lotus Pharmaceutical
NT$283.50-0.7%6.6%NT$74.6bNT$395.20PE15.8xE30.5%2.0%
6472
Bora Pharmaceuticals
NT$498.00-0.1%-20.2%NT$61.8bNT$788.87PE14.6xE20.3%2.3%
6712
Ever Supreme Bio Technology
NT$166.000.9%4.9%NT$14.5bNT$210.00PE27.9xE6.3%2.8%
4162
PharmaEngine
NT$72.201.3%-17.4%NT$10.4bn/aPE6.2xE-88.2%8.3%
6892
Taiwan Bio Therapeutics
NT$29.004.5%-24.9%NT$2.5bn/an/an/an/a
6550
Polaris Group
NT$31.00-6.2%-31.0%NT$23.9bn/aPS337.2xn/an/a
1799
Easywell Biomedicals
NT$34.002.4%-53.4%NT$4.2bn/aPS7.2xn/an/a
1760
Panion & Bf Biotech
NT$63.50-1.7%-22.5%NT$5.4bn/aPE31.2xn/a2.8%
4111
Chi Sheng Pharma & Biotech
NT$29.45-0.8%12.4%NT$1.8bn/aPE10.7xn/a3.2%
6610
TWi Biotechnology
NT$17.403.0%25.2%NT$1.9bn/aPB7xn/an/a
6814
Lukas Biomedical
NT$30.700.3%2.0%NT$1.3bn/aPS7.1xn/an/a
6875
Pharmosa Biopharm
NT$54.00-4.4%-0.7%NT$7.0bn/aPS51xn/an/a
6580
TaiRx
NT$22.45-3.2%-17.2%NT$2.5bn/aPS160.7xn/an/a
6677
Anxo Pharmaceutical
NT$19.85-8.5%-18.6%NT$1.1bn/aPS1.3xn/a2.0%
6885
BRIM Biotechnology
NT$29.00-2.8%-8.7%NT$3.9bn/aPS1217.9xn/an/a
6547
Medigen Vaccine Biologics
NT$37.700%2.9%NT$12.4bNT$102.00PS20.8xn/an/a
4168
GlycoNex Incorporation
NT$24.80-2.9%-4.2%NT$2.7bn/aPS73.3xn/a0%
1720
Standard Chemical & Pharmaceutical
NT$60.101.0%-2.0%NT$10.7bNT$73.00PE12xn/a4.7%
6492
Senhwa Biosciences
NT$42.201.4%-0.8%NT$3.8bn/aPS3484.8xn/an/a
6973
U-Neuron Biomedical
NT$38.207.5%-1.9%NT$1.1bn/an/an/an/a
Page 1 of 6